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Luisa Galli, MD, Bice Lucchesi, PharmD, Alessandro Mugelli, MD, Gian Luigi Marseglia, MD, and Maurizio de Martino, MD,
on behalf of the Italian Pediatric Society Panel for the Management of Fever in Children*
Objective To review new scientific evidence to update the Italian guidelines for managing fever in children as
drafted by the panel of the Italian Pediatric Society.
Study design Relevant publications in English and Italian were identified through search of MEDLINE and the
Cochrane Database of Systematic Reviews from May 2012 to November 2015.
Results Previous recommendations are substantially reaffirmed. Antipyretics should be administered with the purpose
to control the child’s discomfort. Antipyretics should be administered orally; rectal administration is discouraged except
in the setting of vomiting. Combined use of paracetamol and ibuprofen is discouraged, considering risk and benefit.
Antipyretics are not recommended preemptively to reduce the incidence of fever and local reactions in children
undergoing vaccination, or in attempt to prevent febrile convulsions in children. Ibuprofen and paracetamol are not
contraindicated in children who are febrile with asthma, with the exception of known cases of paracetamol- or non-
steroidal anti-inflammatory drug-induced asthma.
Conclusions Recent medical literature leads to reaffirmation of previous recommendations for use of antipyret-
ics in children who are febrile. (J Pediatr 2016;■■:■■-■■).
In 2009, national guidelines for healthcare providers and parents/caregivers on management of fever in children were draftedby an expert panel on behalf of the Italian Pediatric Society.1 A cross-sectional survey was conducted before their publicationand 3 years later to investigate their impact on knowledge and behaviors of pediatricians. A reduction of some incorrect
attitudes of Italian pediatricians was observed during the study interval, in particular the alternating use of antipyretics and
anti-inflammatory drugs (27-11% of pediatricians, P < .001) and the rectal administration of antipyretics in absence of vom-
iting (44-25%, P < .001). Moreover, the rate of pediatricians discouraging physical methods for fever reduction increased (19-
36%, P < .001).2 A first update of the guidelines of the Italian Pediatric Society was published in 2012.3 We aimed to review
guidelines in light of new scientific evidence.
Methods
We identified relevant publications in English and Italian through search of MEDLINE and the Cochrane Database of System-
atic Reviews from May 2012 to November 2015, as previously described.1,3 Updated recommendations were considered using
the previously described methodology.1,3
Results
Methods of Temperature Measurement
Methods and devices for body temperature measurement are controversial. There is no consensus on the best method that is
relatively easy, safe, and noninvasive, to accurately predict core temperature.4 Rectal temperature better reflects the central core
temperature but is a physically and psychologically invasivemethod.5 For this reason,
the Italian guidelines recommend that axillary temperature measurement with a
digital thermometer be used in school and home settings. In hospital or ambu-
latory care settings, an infrared thermometer should be used in children >1 year
of age only by trained healthcare personnel because the use of these devices is prone
to errors when used by untrained persons.3 In infants <1 year of age, in every setting,
for measurements of axillary temperature only the digital thermometer is rec-
ommended because evidence regarding other devices in this age group is poor.5
After the release of the Italian Guidelines, several studies have been published re-
garding the use and the performance of infrared thermometers in different set-
tings and age groups5-16 (Table). Infrared thermometers can be noncontact or contact
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Table. Comparison of temporal artery scan thermometer and other classic methods used to measure body temperature
Authors Year Study design Objective
Population





Allegaert et al5 2014 Observational To assess the accuracy of tympanic,
infrared skin, and temporal artery
scan thermometers to rectal
measurement

















• TT vs RT: 0.49°C (95%
CI 1.69, −0.71) (P < .0001),
• ISS vs RT: 0.34°C (95%
CI 1.60, −0.92) (P < .0001),
• TAT vs RT: 0°C,(95% CI 1.33,
−1.32) (P = .9288).
R
Batra et al4 2013 Observational To compare axillary, temporal artery,
and tympanic membrane
measurement to rectal
measurement in the emergency
department









• TAT vs RT:
febrile 0.99 (P < .0001)
afebrile 0.91 (P < .0001)
• AT vs RT:
febrile 0.95 (P < .0001)
afebrile 0.94 (P < .0001)
R
Hamilton et al7 2013 Observational To compare 2 infrared
thermometers (ThermoScan PRO
4000 [Braun GmbH, Kronberg,
Germany] prewarmed tip ear











• TT vs TAT: 0.17 ± 0.48°C
(CI −0.77, 1.11)
• TT vs CT: −0.01 ± 0.39°C
(CI −0.77, 0.77)
• TAT vs CT: −0.17 ± 0.58°C.
(CI −1.32, 0.98)
Not-R
Hoffman et al8 2013 Observational To compare temporal artery
temperature to RT in febrile
children in an emergency
department.
147, 0-36 mo RT ≥38°C, TAT : 53
RT ≥39°C, TAT: 27
RT ≥38°C, TAT : 97
RT ≥39°, TAT: 79
Mean temperature difference
• TAT and RT: 1.99°F (1.11°C)
(95% CI 1.75°F-2.23°F).
Not-R
Isler et al9 2014 Observational To compare temporal artery or
temporal artery scan
thermometers to mercury and
digital axillary thermometer
measurements.
218, 0-18 y NA NA Mean temperature difference:
• TAT vs Glass-mercury AT:
0.6°C, SE 0.08, P = .000
• TAT vs digital AT: 0.9°C SE
0.08, P = .001
• Mercury AT vs digital AT:
0.6°C, SE 0.08 P = .000
R
Moore et al10 2014 Observational To compared temporal artery scan
thermometers to detect high RT
in children in emergency
department.
239, 91 d-4 y All subjects:
TAT >38°C :
• RT ≥38°C: 56 (95% CI 54, 58)
• RT ≥39°C: 75 (95% CI 73,77)
Injured subject:
TAT > 38°C:
• RT ≥38°C: 67 (95% CI 65,69)
• RT ≥39°C: 100 (95% CI 98, 102)
All subject:
38°C TA cut-off:
• RT ≥38°C: 93
(95% CI 92, 96)




• RT ≥38°C:10 (95% CI 98, 102)
• RT ≥39°C: 10
(95% CI 98, 102)
Mean RT (38.05 ± .99°C) vs



















































Authors Year Study design Objective
Population





Odinaka et al11 2014 Observational To compare temporal artery
measurement to rectal
measurement.
156, <5 y RT >38.0°C,
TAT >38.0°C: 64.6
RT >38°C, TAT >37.7°C: 83.5
RT > 38.0°C, TAT > 38.0°C: 94.8
RT > 38°C, TAT > 37.7°C: 88.3
Mean temperature difference:




TAT vs RT 0.02 ± 0.59°C
(P = .810).
Positive correlation between the
RT and TAT
r = 0.80 (P < .01).
Not-R
Reynolds et al12 2014 Observational To compare the accuracy of
temporal artery temperatures and
axillary temperatures to RT in
pediatric emergency department.









Teran et al15 2012 Observational To compare the infrared NCT
(Thermofocus [Technimed,
Varese, Italy]) to temporal artery
scan thermometers and RT.
434, 1-48 mo RT ≥38:
• NCT: 97 (95% CI 92.7-98.8)






Mean temperature difference :
• NCT vs RT: 0.029 ± 0.01°C
(P < .001).
• TAT vs RT: −0.20 ± 0.27°C
(P < .001).
Not-R






































devices. Noncontact thermometers measure the emitted in-
frared heat of various parts of the body,mainly from the fore-
head, without direct skin contact. A particular noncontact
infrared thermometer, the tympanic scan, measures infrared
heat produced by the tympanic membrane.5 A study compar-
ing tympanic vs traditional methods (rectal and axillary mea-
surement) in 400 children under 5 years of age showed no
significant difference between recorded rectal and tympanic
temperatures (mean temperature: 38.8°C vs 38.7°C, respec-
tively; P = .14). Moreover, the sensitivity in determining fever
by tympanic thermometer was higher compared with axillary
measurement (92%vs 54%).6 This studywas included in a recent
meta-analysis of 25 studies on infrared tympanic tempera-
ture measurement, including 5749 children.16 The calculated
pooled sensitivity and specificity of thismethodwas 70% (95%
CI 68 and 72) and 86% (95% CI 85 and 88), respectively. The
authors also concluded that tympanicmeasurement seems not
to be influenced by surgical procedures, injuries of tympanic
membrane, otitis media, baby-crying, effusion, and cerumen
in the ear.16 In another study including 434 children, a high
sensitivity (97%; 95% CI 92.7 and 98.8) and specificity (97%;
95% CI 93.9 and 98.6) of noncontact skin infrared method to
detect fever was found.15 The main reported limitation of this
device seems to be its lower accuracy in presence of irritability
and sweating, which is common in children who are febrile.
The performance of other noncontact infrared devices for de-
tecting fever in influenza epidemics has been assessed recently
with discordant results.13
Contact thermometers are divided into temporal artery and
axillary sites. Temporal artery thermometermeasures the natu-
rally emitted infrared heat from the temporal artery on the fore-
head and themastoid area adjusted for the skin temperature.5,11,15
Temporal artery thermometer is a hygienic, quick, and non-
invasive method. However, data on its accuracy in the diag-
nosis of fever are conflicting.5 The use of temporal artery
thermometer has been assessed in 9 studies totaling 1845 chil-
dren (Table).3,5,7-12,14,15 The results of these studies are contro-
versial. Four studies support the use of temporal artery
thermometer in children as an alternative noninvasivemethod
in the emergency department setting.4,5,9,12 Reynolds et al12 found
that the temporal artery measurement bias was −0.46°C with
limits of agreement of ±0.5°C compared with rectal measure-
ment. The bias and precision values of this method was within
the acceptable range set by experts,making it suitable for body
temperature detection in children younger than 4 years of age.12
In a recent study, authors conclude that temporal artery ther-
mometer tends to overestimate lower temperatures and un-
derestimate higher temperatures.5 Five other studies do not
support the use of temporal artery thermometer for fever de-
tection in children.7,8,10,11,15 In a large study, including 205 chil-
dren recruited in an emergency department inArgentina,overall
false-negative ratewas 3-fold higher using temporal artery ther-
mometer compared with tympanic infrared thermometer.7 In
the study by Moore et al,10 the overall sensitivity and speci-
ficity of temporal artery measurement in detecting high fever
was low (75% and 85%, respectively). However, the authors
encouraged the use of temporal artery thermometer in selected
populations, such as injured children, inwhom temporal artery
thermometer was found to have a sensitivity and specificity of
100%.Amajor study limitationwas the small number of injured
children studied (n = 27). Two studies have been conducted
in neonates showing conflicting results.11,17 The available data
do not permit a definitive conclusion on the use of temporal
artery thermometer in the pediatric population.
Recommendation. Axillary temperature measurement using
a digital thermometer is recommended in children younger
than 4 weeks of age in all settings (evidence level III; strength
of recommendation, B). In the hospital or ambulatory care
setting, axillary temperature measurement using a digital ther-
mometer or an infrared thermometer (tympanic or with or
without skin contact) is recommended in children older than
4 weeks (evidence level II; strength of recommendation, B).
Use of Antipyretic Drugs
Paracetamol and ibuprofen are the only antipyretic drugs rec-
ommended for use in children. The existing debate regards their
combined use.18,19 A Cochrane review of 6 trials, including 915
children, reported that paracetamol and ibuprofen use in chil-
dren who are led to a lower mean temperature at 1 and 4 hours
compared with use of a single antipyretic (mean difference at
1 hour: −0.27°C; 95% CI −0.4 and −0.08; mean difference at
4 hours: −0.70°C; 95% CI −1.05 and 0.35).20 Moreover, alter-
nating paracetamol and ibuprofen when fever fails to resolve
or recurs after a dose of a single agent, might result in a lower
mean temperature at 1 hour after the second dose (mean dif-
ference −0.60°C, 95%CI −0.94 and −0.26).Although no serious
adverse event was reported in this systematic review, the authors
raise the concern for limited safety assessment of the com-
bined and alternating regimens.20
In a randomized comparative trial conducted on 99 chil-
dren who are febrile aged 6months to 12 years, themean tym-
panic temperature in the combined paracetamol and ibuprofen
group was significantly lower compared with the paracetamol
group 4 hours after drug administration (mean reduction in
temperature 2.19 ± 0.83 vs 1.48 ± 0.94; P < .05).21 The authors
noted that, despite the statistically significant different tem-
perature reduction between the 2 groups, the difference was
not clinically relevant.Moreover, no significant differenceswere
observed between ibuprofen alone and combination treat-
ment (P = .167) and between paracetamol and ibuprofen
monotherapy (P = .102).21 Also, there are concerns about the
increased risk of inaccurate dosages using combined or alter-
nating regimens.
The National Institute for Health and Care Excellence update
guidance of May 2013 does not recommend the combina-
tion of paracetamol and ibuprofen.22 The alternating regimen
could be considered in children who are febrile only in the case
of persistent or recurrent distress.22 In conclusion, based on
previous studies and considering the lack of safety trials, the
combined or alternating use of paracetamol and ibuprofen is
not recommended in children.Moreover, alternating use of an-
tipyretics may encourage fever phobia. Compared with ibu-
profen, paracetamol can be used in infants under 3 months
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of age as well as in cases of dehydration.18 Moreover, ibuprofen
is not recommended in chickenpox or Kawasaki disease and
can cause severe acute kidney injury, even when correctly dosed
(reference). A systematic review of 13 unpublished and 40 pub-
lished clinical trials,23 enrolling 3037 children overall who re-
ceived an oral dose of 10-15 mg/kg of paracetamol, concluded
that dosage recommendation remains appropriate.24 More-
over, compared with 10 mg/kg, the dosage of 15 mg/kg appears
to maintain low temperature for longer time and to be more
effective in decreasing the mean temperature from baseline
(1.6°C vs 1.2°C).24 A retrospective analysis of paracetamol-
associated acute liver failure in 14 children showed hepato-
toxicity was mainly related to medication error, specifically in
relation to dosage, frequency, and length of treatment.25 In
general, it should be remembered that toxicity in children tends
to occur after administration of single doses ranging from 120
to 150 mg/kg, corresponding to 10-15 times the recom-
mended dosage.1 Therefore, paracetamol should be used at the
dosage of 40 mg/kg per day, divided in 4 doses. At this dosage,
paracetamol appears to be as safe and effective as ibuprofen.
Recommendations. Paracetamol and ibuprofen are the only
antipyretic drugs recommended for use in children (evi-
dence level I; strength of recommendation, A). Combined or
alternating use of ibuprofen and paracetamol is not recom-
mended (evidence level VI; strength of recommendation, D).
Antipyretics at Immunization Episodes
One study is available on the use of antipyretics to prevent febrile
and other common vaccination reactions associatedwith child-
hoodvaccinations.26 In this trial,301healthy infants (<14months
of age) who received routine 7-valent pneumococcal conju-
gate vaccine co-administeredwith hexavalent vaccinewere ran-
domized to receive no paracetamol or 2 doses of paracetamol
(at the vaccination and 6-8 hours after vaccination).26
Paracetamol use was significantly associated with reduction of
fever ≥38°C in children receiving the infant vaccine doses (2,
3, and 4 months), with a computed efficacy of 43% (95% CI
17.4 and 61.2), whereas use was not statistically significant for
the toddler dose (11-14months) (efficacy 15.9%; 95%CI−19.9
and 41.3). Authors concluded that use of paracetamol might
not be justified considering that fever was rarely >39°C, and
the other adverse events usually weremild and of no concern.26
This study was included in a systematic review of 13 ran-
domized controlled trials of antipyretic usewith immunization.27
Overall, 5077 children were included. A significant reduction
of temperature ≥38.0°C was seen in the first 24-48 hours in
the prophylactic paracetamol group compared with placebo
both after primary (OR0.35; 95%CI 0.26 and 0.48) and booster
(OR 0.60; 95% CI 0.39 and 0.93) vaccinations. In this system-
atic review, the antibody response to vaccinations was as-
sessed in children receiving the paracetamol prophylactically.
The geometric mean concentrations of antibody was lower in
the prophylactic group after primary and booster vaccination
for all the pneumococcal vaccine serotypes, tetanus, and diph-
theria. However, antibody levels were still above correlates of
protection.27 The authors conclude that available data are
inclusive to establish the real clinical and epidemiologic rel-
evance of this finding.
Paracetamol has been studied when given prophylactically
at the time of the multicomponent meningococcal serogroup
B vaccination.28 This vaccine was highly reactogenic with 70%
of immunized infants having fever ≥38.5°C at least once in the
first 3 days after the primary dose. Fever was less common
(39%) in infants receiving paracetamol prophylactically just
before or at the time of vaccination followed by 2 further ad-
ministrations at 4- to 6-hour intervals.
Neither the American Academy of Pediatrics nor the US Ad-
visory Committee on Immunization Practices of the Centers
for Disease Control and Prevention recommends antipyret-
ics before or at the time of immunization.29,30 Cited reasons
are lack of evidence to support use, lack of demonstrable effect
in prevention of febrile seizures in children who had a previ-
ous febrile seizure, and concern for potential detrimental effect
on the immune response to the vaccine(s) being adminis-
tered. Neither organization is opposed to use of antipyretic
should fever or local discomfort occur following vaccination.
Recommendations. Use of paracetamol or ibuprofen is not
recommended prophylactically to reduce the incidence of fever
and local reactions in children undergoing vaccination (evi-
dence level II; strength of recommendation E).
Antipyretics to Prevent Febrile Convulsions
Arecentmeta-analysis of 3 studies, includingoverall 540 children
(6-72 months of age) with previous febrile seizures, assessed
the use of antipyretics for prevention of febrile convulsions.31
In this study, no statistically significant difference was found
in the rate of febrile seizures between children who received
prophylactic antipyretics or placebo (OR 0.9, 95%CI 0.57 and
1.43).31
Recommendation. Preventive use of paracetamol or
ibuprofen is not recommended for the prevention of febrile
convulsions in children (evidence level I; strength of recom-
mendation E).
Paracetamol and Risk of Asthma
Association between paracetamol administration andwheezing
episode was studied in a double blind placebo-controlled trial,
conducted on 42 children with asthma and 21 healthy age-
matched controls.32 This study showed no bronchoconstriction
and no increase in airway inflammation 60 minutes after the
administration of a single dose of paracetamol in childrenwith
asthma.Measurements of fractional exhaled nitric oxide, forced
expiratory volume in1 second,Tiffenau index,and forced expira-
tory flow between 25% and 75% were not significantly diffe-
rent between the 2 groups (fractional exhalednitric oxideP = .14;
forced expiratory volume in 1 second P = .87; Tiffenau index
P = .53; forced expiratory flowbetween 25%and 75%P = .48).32
In a systematic review, Heintze et al33 proposed that the pre-
vious studies suggesting an association between paracetamol
and asthma might be affected by confounding variables and
bias, such as the lack of adjustment for indications for
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paracetamol in the cross-sectional studies. A recent meta-
analysis of 6 studies evaluated the paracetamol intake in the
first 2 years of life and the development of asthma.34 The com-
parison between any paracetamol and no paracetamol admin-
istration showed a significant correlation with asthma (OR 1.56,
95% CI 1.07 and 2.26; adjusted for respiratory tract infec-
tion: OR 1.41, 95% CI 0.96 and 2.08). In the 3 studies strati-
fying for frequency of intake, an increased risk of asthma was
observed in children who received a higher number of doses
(OR 1.15, 95% CI 1.00 and 1.31). After adjustment for respi-
ratory tract infections, it was not significant (OR 1.06, 95%
CI 0.92 and 1.22), suggesting likely confounding by indication.34
Recommendation. Use of ibuprofen and paracetamol is not
contraindicated in children who are febrile with asthma.
Paracetamol and ibuprofen are contraindicated in known cases
of paracetamol- or NSAID-induced asthma (evidence level I;
strength of recommendation A).
Discussion
Overall, the recent available literature is mainly in accor-
dance with the previous recommendations and support their
continued applicability in clinical practice. Implementation and
periodic update of available guidelines are pivotal to affect-
ing appropriate clinical behavior of pediatricians regarding the
management of fever in childhood. ■
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Appendix
Italian Pediatric Society Panel for the Management of Fever
in Children includes:
Writing Committee—Elena Chiappini, PhD, Elisabetta
Venturini,MD,Giulia Remaschi,MD, Filippo Festini, RN, Luisa
Galli, MD, Maurizio de Martino, MD, Francesca Bonsignori,
MD, and AlessandroMugelli,MD (University of Florence, Flor-
ence, Italy); Nicola Principi, MD, and Susanna Esposito, MD
(Pediatric Highly Intensive Care Unit, Department of Patho-
physiology and Transplantation, Università degli Studi di
Milano, Fondazione Istituto di Ricovero e Cura a Carattere
Scientifico Ca’ Granda Ospedale Maggiore Policlinico, Milan,
Italy); Riccardo Longhi,MD (Sant’Anna Hospital, Como, Italy);
Pier-Angelo Tovo,MD (University of Milan,Milan, Italy); Paolo
Becherucci, MD (Primary Care Practice, Florence, Italy); Bice
Lucchesi, RPh (Health Authority 1, Massa, Italy); Gian Luigi
Marseglia, MD (Istituto di Ricovero e Cura a Carattere
Scientifico Foundation, Pavia, Italy).
Other participants in the Italian Pediatric Society Panel on
the Management of Fever in Children—
Andrea deMaria,MD (University of Genova, Genova, Italy);
Giacomo Faldella,MD (University of Bologna, Bologna, Italy);
Paola Pecco,MD (Children’s Hospital ReginaMargherita, Turin,
Italy); Simona Squaglia,MD (Health Authority C, Rome, Italy);
Paolo Tambaro,MD (primary care pediatrician, Caserta, Italy);
Pasquale Tulimiero, (President of the Parents’ Association Noi
per Voi, Florence, Italy); and Giorgio Zavarise, MD (Hospital
Sacro Cuore-Don Calabria, Verona, Italy).
Scientific societies represented on the panel were the
Italian Pediatric Society, the Italian Society of Pediatric
Infectious Diseases, the Clinical Section of the Italian Society
of Pharmacology, the Italian Society of Neonatology, the
Italian Society of Pediatric Emergency and Urgent Medicine,
the Italian Federation of Pediatricians, the Italian Society of
Pediatric Nursing Sciences, and the parents’ association Noi
per Voi.
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